CVS Health Return on Tangible Equity 2010-2025 | CVS

Current and historical return on tangible equity values for CVS Health (CVS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
CVS Health Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $5.28B $-40.66B -12.28%
2024-12-31 $4.61B $-42.87B -10.41%
2024-09-30 $5.02B $-43.98B -11.26%
2024-06-30 $7.19B $-44.47B -15.92%
2024-03-31 $7.32B $-45.89B -15.87%
2023-12-31 $8.34B $-43.87B -18.81%
2023-09-30 $8.63B $-46.38B -20.95%
2023-06-30 $2.97B $-48.38B -7.87%
2023-03-31 $4.09B $-38.85B -12.27%
2022-12-31 $4.31B $-31.18B -13.46%
2022-09-30 $3.37B $-32.23B -10.41%
2022-06-30 $8.38B $-31.19B -25.49%
2022-03-31 $8.13B $-33.46B -23.86%
2021-12-31 $8.00B $-32.77B -22.55%
2021-09-30 $7.58B $-34.05B -20.19%
2021-06-30 $7.20B $-36.07B -18.21%
2021-03-31 $7.40B $-39.03B -17.81%
2020-12-31 $7.18B $-40.99B -16.47%
2020-09-30 $7.95B $-42.16B -17.48%
2020-06-30 $8.26B $-43.93B -17.37%
2020-03-31 $7.22B $-47.25B -14.57%
2019-12-31 $6.63B $-48.70B -12.93%
2019-09-30 $4.47B $-50.27B -8.38%
2019-06-30 $4.33B $-52.05B -9.97%
2019-03-31 $-0.17B $-54.22B 0.51%
2018-12-31 $-0.59B $-56.66B 2.58%
2018-09-30 $3.11B $-10.76B -24.94%
2018-06-30 $3.01B $-11.93B -21.58%
2018-03-31 $6.67B $-12.83B -43.62%
2017-12-31 $6.62B $-14.39B -40.05%
2017-09-30 $5.04B $-16.60B -30.25%
2017-06-30 $5.30B $-17.34B -32.15%
2017-03-31 $5.12B $-17.81B -31.22%
2016-12-31 $5.32B $-14.93B -33.41%
2016-09-30 $5.11B $-15.83B -32.17%
2016-06-30 $4.81B $-17.06B -31.50%
2016-03-31 $5.16B $-15.83B -46.14%
2015-12-31 $5.24B $-14.78B -70.30%
2015-09-30 $5.06B $-13.46B -135.19%
2015-06-30 $4.76B $-0.67B -1352.84%
2015-03-31 $4.74B $-0.89B -2978.62%
2014-12-31 $4.64B $0.05B 5495.86%
2014-09-30 $4.59B $0.10B 850.42%
2014-06-30 $4.89B $0.10B 439.36%
2014-03-31 $4.77B $0.09B 270.62%
2013-12-31 $4.59B $1.87B 207.43%
2013-09-30 $4.44B $2.40B 209.25%
2013-06-30 $4.20B $2.70B 247.46%
2013-03-31 $4.04B $1.90B 284.10%
2012-12-31 $3.86B $1.51B 275.12%
2012-09-30 $3.81B $0.69B 261.30%
2012-06-30 $3.68B $1.60B 237.94%
2012-03-31 $3.53B $1.82B 230.92%
2011-12-31 $3.46B $1.72B 202.34%
2011-09-30 $3.42B $1.03B 185.86%
2011-06-30 $3.36B $1.53B 181.32%
2011-03-31 $3.37B $2.56B 219.23%
2010-12-31 $3.43B $2.25B 384.09%
2010-09-30 $3.45B $1.09B 1076.23%
2010-06-30 $3.66B $0.25B 34083.72%
2010-03-31 $3.73B $-0.02B 9150.92%
2009-12-31 $3.70B $-0.04B -3820.16%
Sector Industry Market Cap Revenue
Medical Medical Services $84.870B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.092B 26.27
Elevance Health (ELV) United States $84.768B 10.94
Cencora (COR) United States $56.829B 19.77
Natera (NTRA) United States $22.878B 0.00
DiDi Global (DIDIY) China $22.356B 23.75
Labcorp Holdings (LH) United States $21.716B 17.61
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.887B 0.00
Solventum (SOLV) United States $12.588B 13.33
CochLear (CHEOY) Australia $12.104B 0.00
ICON (ICLR) Ireland $11.456B 10.65
Revvity (RVTY) United States $11.099B 19.10
Doximity (DOCS) United States $10.990B 50.88
Viatris (VTRS) United States $10.281B 3.53
Avantor (AVTR) United States $8.961B 13.02
HealthEquity (HQY) United States $8.648B 37.88
Medpace Holdings (MEDP) United States $8.563B 22.74
Sonic Healthcare (SKHHY) Australia $8.268B 0.00
Charles River Laboratories (CRL) United States $7.124B 13.96
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.096B 24.12
BrightSpring Health Services (BTSG) United States $3.753B 34.44
Sotera Health (SHC) United States $3.108B 17.66
Alignment Healthcare (ALHC) United States $2.883B 0.00
Concentras Parent (CON) United States $2.704B 15.63
Surgery Partners (SGRY) United States $2.605B 33.88
Organon (OGN) United States $2.561B 2.72
PACS (PACS) United States $1.882B 0.00
Progyny (PGNY) United States $1.846B 40.62
Premier (PINC) United States $1.832B 13.91
GeneDx Holdings (WGS) United States $1.827B 70.37
Ardent Health (ARDT) United States $1.818B 7.75
GoodRx Holdings (GDRX) United States $1.568B 31.36
Teladoc Health (TDOC) United States $1.242B 0.00
Pediatrix Medical (MD) United States $1.152B 8.76
CareDx (CDNA) United States $1.087B 16.97
Establishment Labs Holdings (ESTA) $1.082B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.869B 0.00
AMN Healthcare Services Inc (AMN) United States $0.842B 7.88
QDM (QDMI) Hong Kong, SAR China $0.758B 0.00
Nutex Health (NUTX) United States $0.642B 9.71
LifeMD (LFMD) United States $0.617B 0.00
Embecta (EMBC) United States $0.575B 3.87
InnovAge Holding (INNV) United States $0.505B 0.00
Enhabit (EHAB) United States $0.485B 39.92
Auna S.A (AUNA) Luxembourg $0.472B 10.63
SBC Medicals (SBC) United States $0.469B 0.00
Sonida Senior Living (SNDA) United States $0.454B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.419B 0.00
Omada Health (OMDA) $0.390B 0.00
Performant Healthcare (PHLT) United States $0.261B 0.00
Oncology Institute (TOI) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.193B 0.00
DocGo (DCGO) United States $0.163B 26.67
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.115B 0.00
So-Young (SY) China $0.104B 0.00
OncoCyte (OCX) United States $0.092B 0.00
KindlyMD (NAKA) United States $0.089B 0.00
Sera Prognostics (SERA) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.052B 0.00
Basel Medical Group (BMGL) Singapore $0.050B 0.00
ModivCare (MODV) United States $0.047B 0.00
Biodesix (BDSX) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.032B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00